InsituGen
PrivateLast Round
VC Round
Jan 1, 2026
Est. Valuation
$4.67M
Total Funding Raised
$1.6M
Company Overview
InsituGen operates in Healthcare & Life Sciences and is based in Dunedin. Its latest recorded funding round was a Grant round in October 2020.
InsituGen is a biotechnology company that has developed a bioassay technology platform to detect androgen and estrogen bioactivity for applications in anti-doping, supplement testing, and animal wellness.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Compliance & Risk
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InsituGen Comparables
Compare InsituGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Assay Genie | 70% | |
| Abcam | 63% | |
| Thermo Fisher Scientific Inc. | 62% |
For institutional investors. Book with your work email.
InsituGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 1, 2026 | ||||
| Grant | Oct 15, 2020 | ||||
| Seed | Oct 15, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InsituGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Callaghan Innovation | Grant |
| New Zealand Growth Capital Partners | Seed |
| Booster Innovation Fund | Seed |
| Enterprise Angels | Seed |
| Pacific Channel | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 44% MoM.
- Mar 5, 2026
Monthly visitors increased 2527% MoM, reaching 1.4K.
For institutional investors. Book with your work email.
InsituGen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InsituGen's valuation, stock price, and market status.
Is InsituGen a public or private company?
InsituGen is a private company.
What is the current stock price of InsituGen?
InsituGen is a private company, so its shares have no public market price. Caplight tracks InsituGen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InsituGen worth (valuation)?
InsituGen's valuation is estimated at $4.7M based on funding round data.
Can I buy InsituGen stock?
InsituGen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InsituGen's last funding round?
InsituGen's most recent funding round was VC Round on January 1, 2026.
Who are the main investors in InsituGen?
Key investors in InsituGen include Pacific Channel.
Will InsituGen IPO soon?
No public IPO plans have been announced for InsituGen.
How can I track InsituGen secondary market activity?
Caplight tracks bids, offers, and trades in InsituGen's shares on secondary markets.